1 Introduction
1.1 Report Description
1.1.1 Segmentation and Research Scope
1.1.2 Definition, Abbreviations, and Assumptions
1.2 Research Methodology
1.2.1 Methodology
1.2.2 Research Methodology: An Outline
1.3 Research Approaches
2 Executive
Summary
2.1 Brazil Drug of Abuse Testing Market
Highlights, (USD Million)
2.2 Brazil Drug of Abuse Testing Market Projection
3 Market Overview
& Competitiveness
3.1 DRO Analysis
3.1.1 Drivers
3.1.1.1 Accelerating consumption of cocaine in Brazil
3.1.1.2 Increasing government measures to control drug
abuse in Brazil
3.1.2 Challenge
3.1.2.1 Inadequate infrastructure for providing drug
testing services and low threshold of drug abuse testing laws in Brazil
3.1.3 Opportunities
3.1.3.1 Rising trends of prescription opioid sales in Brazil
3.2 COVID-19 IMPACT Analysis of Brazil Drug
of Abuse Testing Market
3.3 PEST-Analysis of Brazil Drug of Abuse Testing
Market
3.4 Porter's Diamond Model for Brazil Drug
of Abuse Testing Market
3.5 IGR- Growth Matrix Analysis
3.6 Competitive Landscape in the Drug of Abuse
Testing Market
3.6.1 Company Shares
4 Brazil Drug of
Abuse Testing Market, By Product Type
4.1 Introduction
4.1.1 Analyzers
4.1.1.1 Immunoassays Analyzers
4.1.1.2 Chromatographic Devices
4.1.1.3 Breath Analyzers
4.1.2 Rapid Testing Devices
4.1.2.1 Urine Testing Devices
4.1.2.2 Oral Fluid Testing Devices
4.1.3 Consumables
5 Brazil Drug of
Abuse Testing Market, By Sample Type
5.1 Introduction
5.1.1 Saliva
5.1.2 Urine
5.1.3 Blood
5.1.4 Other Sample Types
6 Brazil Drug of
Abuse Testing Market, By End User
6.1 Introduction
6.1.1 Hospitals
6.1.2 Diagnostic Laboratories
6.1.3 Forensic Laboratories
6.1.4 Other End Users
7 Company
Profiling
7.1 Thermo Fisher Scientific Inc.
7.1.1.1 Overview
7.1.1.2 Company Snapshot
7.1.1.3 Product Portfolio
7.2 Siemens AG
7.2.1 Overview
7.2.2 Company Overview
7.2.3 Product Portfolio
7.3 NEOGEN Corporation
7.3.1 Overview
7.3.2 Company Overview
7.3.3 Product Portfolio
7.4 Xiamen Boson Biotech Co., Ltd
7.4.1 Overview
7.4.2 Company Overview
7.4.3 Product Portfolio
7.5 Beckman Coulter, Inc. (Danaher
Corporation)
7.5.1 Overview
7.5.2 Company Overview
1 Introduction
1.1 Report Description
1.1.1 Segmentation and Research Scope
1.1.2 Definition, Abbreviations, and Assumptions
1.2 Research Methodology
1.2.1 Methodology
1.2.2 Research Methodology: An Outline
1.3 Research Approaches
2 Executive
Summary
2.1 Brazil Drug of Abuse Testing Market
Highlights, (USD Million)
2.2 Brazil Drug of Abuse Testing Market Projection
3 Market Overview
& Competitiveness
3.1 DRO Analysis
3.1.1 Drivers
3.1.1.1 Accelerating consumption of cocaine in Brazil
3.1.1.2 Increasing government measures to control drug
abuse in Brazil
3.1.2 Challenge
3.1.2.1 Inadequate infrastructure for providing drug
testing services and low threshold of drug abuse testing laws in Brazil
3.1.3 Opportunities
3.1.3.1 Rising trends of prescription opioid sales in Brazil
3.2 COVID-19 IMPACT Analysis of Brazil Drug
of Abuse Testing Market
3.3 PEST-Analysis of Brazil Drug of Abuse Testing
Market
3.4 Porter's Diamond Model for Brazil Drug
of Abuse Testing Market
3.5 IGR- Growth Matrix Analysis
3.6 Competitive Landscape in the Drug of Abuse
Testing Market
3.6.1 Company Shares
4 Brazil Drug of
Abuse Testing Market, By Product Type
4.1 Introduction
4.1.1 Analyzers
4.1.1.1 Immunoassays Analyzers
4.1.1.2 Chromatographic Devices
4.1.1.3 Breath Analyzers
4.1.2 Rapid Testing Devices
4.1.2.1 Urine Testing Devices
4.1.2.2 Oral Fluid Testing Devices
4.1.3 Consumables
5 Brazil Drug of
Abuse Testing Market, By Sample Type
5.1 Introduction
5.1.1 Saliva
5.1.2 Urine
5.1.3 Blood
5.1.4 Other Sample Types
6 Brazil Drug of
Abuse Testing Market, By End User
6.1 Introduction
6.1.1 Hospitals
6.1.2 Diagnostic Laboratories
6.1.3 Forensic Laboratories
6.1.4 Other End Users
7 Company
Profiling
7.1 Thermo Fisher Scientific Inc.
7.1.1.1 Overview
7.1.1.2 Company Snapshot
7.1.1.3 Product Portfolio
7.2 Siemens AG
7.2.1 Overview
7.2.2 Company Overview
7.2.3 Product Portfolio
7.3 NEOGEN Corporation
7.3.1 Overview
7.3.2 Company Overview
7.3.3 Product Portfolio
7.4 Xiamen Boson Biotech Co., Ltd
7.4.1 Overview
7.4.2 Company Overview
7.4.3 Product Portfolio
7.5 Beckman Coulter, Inc. (Danaher
Corporation)
7.5.1 Overview
7.5.2 Company Overview